Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.439
Delayed Data
As of Jul 22
 +0.0276 / +6.71%
Today’s Change
0.21
Today|||52-Week Range
0.60
+4.45%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.41
Today’s open0.43
Day’s range0.41 - 0.44
Volume2,895,415
Average volume (3 months)2,492,560
Market cap$84.7M
Dividend yield--
Data as of 4:01pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.06-3.75%
ATNMActinium Pharmaceuti...+0.07+4.12%
CERUCerulean Pharma Inc+0.09+3.15%
CEMIChembio Diagnostics ...+0.11+1.32%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
Chief Financial Officer, CAO &
Senior VP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs